PPARα induces cell apoptosis by destructing Bcl2

被引:40
作者
Gao, Jiaming [1 ,2 ]
Liu, Qian [1 ]
Xu, Ying [2 ]
Gong, Xin [2 ]
Zhang, Runyun [2 ]
Zhou, Chenglin [3 ]
Su, Zhaoliang [4 ,5 ]
Jin, Jianhua [1 ]
Shi, Haifeng [2 ]
Shi, Juanjuan [2 ]
Hou, Yongzhong [1 ,2 ]
机构
[1] Jiangsu Univ, Affiliated Wujin Peoples Hosp, Dept Oncol, Changzhou, Jiangsu, Peoples R China
[2] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China
[3] Jiangsu Taizhou Peoples Hosp, Taizhou, Jiangsu, Peoples R China
[4] Jiangsu Univ, Sch Med, Dept Immunol, Zhenjiang, Jiangsu, Peoples R China
[5] Jiangsu Univ, Sch Med, Immunol Lab, Zhenjiang, Jiangsu, Peoples R China
关键词
ubiquitination; degradation; apoptosis; PPAR alpha; Bcl2; ACTIVATED RECEPTOR-ALPHA; CANCER-CELLS; PEROXISOME PROLIFERATORS; FENOFIBRATE; GAMMA; EXPRESSION; NF-KAPPA-B/P65; TUMORIGENESIS; DEGRADATION; COLITIS;
D O I
10.18632/oncotarget.5988
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PPAR alpha belongs to the peroxisome-proliferator-activated receptors (PPARs) family, which plays a critical role in inhibiting cell proliferation and tumorigenesis, while the molecular mechanism is still unclear. Here we report that PPAR alpha serves as an E3 ubiquitin ligase to govern Bcl2 protein stability. PPAR alpha physically bound to Bcl2 protein. In this process, PPAR alpha/C102 was critical for PPAR alpha binding to BH3 domain of Bcl2, subsequently, PPAR alpha transferred K48-linked polyubiquitin to lysine-22 site of Bcl2 resulting in its ubiquitination and proteasome-dependent degradation. Importantly, overexpression of PPAR alpha enhanced cancer cell chemotherapy sensitivity. In contrast, silenced PPAR alpha decreased this event. These findings revealed a novel mechanism of PPAR alpha governed endogenous Bcl2 protein stability leading to reduced cancer cell chemoresistance, which provides a potential drug target for cancer treatment.
引用
收藏
页码:44635 / 44642
页数:8
相关论文
共 27 条
  • [1] RING Domain E3 Ubiquitin Ligases
    Deshaies, Raymond J.
    Joazeiro, Claudio A. P.
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2009, 78 : 399 - 434
  • [2] PPARα regulates tumor progression, foe or friend?
    Gao, Jiaming
    Yuan, Shuping
    Jin, Jianhua
    Shi, Juanjuan
    Hou, Yongzhong
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 765 : 560 - 564
  • [3] Targeting 3-phosphoinositide-dependent protein kinase 1 by N-acetyl-cysteine through activation of peroxisome proliferators activated receptor alpha in human lung cancer cells, the role of p53 and p65
    Hann, Swei Sunny
    Zheng, Fang
    Zhao, Shunyu
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2013, 32
  • [4] MECHANISMS OF DISEASE Cell Death
    Hotchkiss, Richard S.
    Strasser, Andreas
    McDunn, Jonathan E.
    Swanson, Paul E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (16) : 1570 - 1583
  • [5] Inhibitor of growth 4 induces NFκB/p65 ubiquitin-dependent degradation
    Hou, Y.
    Zhang, Z.
    Xu, Q.
    Wang, H.
    Xu, Y.
    Chen, K.
    [J]. ONCOGENE, 2014, 33 (15) : 1997 - 2003
  • [6] Bcl2 impedes DNA mismatch repair by directly regulating the hMSH2-hMSH6 heterodimeric complex
    Hou, Yongzhong
    Gao, Fengqin
    Wang, Qinhong
    Zhao, Jinfeng
    Flagg, Tammy
    Zhang, Yangde
    Deng, Xingming
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (12) : 9279 - 9287
  • [7] PPARγ is an E3 ligase that induces the degradation of NFκB/p65
    Hou, Yongzhong
    Moreau, France
    Chadee, Kris
    [J]. NATURE COMMUNICATIONS, 2012, 3
  • [8] Kaklamanis L, 1996, J PATHOL, V179, P10
  • [9] The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy
    Kelly, P. N.
    Strasser, A.
    [J]. CELL DEATH AND DIFFERENTIATION, 2011, 18 (09) : 1414 - 1424
  • [10] Fenofibrate represses interleukin-17 and interferon-γ expression and improves colitis in interleukin-10-deficient mice
    Lee, Jimmy W.
    Bajwa, Poonam J.
    Carson, Monica J.
    Jeske, Daniel R.
    Cong, Yingzi
    Elson, Charles O.
    Lytle, Christian
    Straus, Daniel S.
    [J]. GASTROENTEROLOGY, 2007, 133 (01) : 108 - 123